2013

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

Editors:

ISBN: 978-1-4614-7939-0 (Print) 978-1-4614-7940-6 (Online)

Table of contents (14 chapters)

  1. Front Matter

    Pages i-ix

  2. No Access

    Book Chapter

    Pages 1-9

    Endocannabinoids and Monoamines: Modulating the Modulators

  3. No Access

    Book Chapter

    Pages 11-24

    Endocannabinoid-Mediated Synaptic Plasticity

  4. No Access

    Book Chapter

    Pages 25-54

    Current Cannabinoid Receptor Nomenclature and Pharmacological Principles

  5. No Access

    Book Chapter

    Pages 55-71

    Cue-Elicited Craving for Cannabis Activates the Reward Neurocircuitry Associated with the Neuropathology of Addiction

  6. No Access

    Book Chapter

    Pages 73-101

    Cannabinoid Modulation of Dopaminergic Circuits in Neurodegenerative and Neuropsychiatric Disorders

  7. No Access

    Book Chapter

    Pages 103-134

    Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers

  8. No Access

    Book Chapter

    Pages 135-156

    Anatomical, Biochemical, and Behavioral Evidence for Cannabinoid Modulation of Noradrenergic Circuits: Role of Norepinephrine in Cannabinoid-Induced Aversion

  9. No Access

    Book Chapter

    Pages 157-172

    Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function

  10. No Access

    Book Chapter

    Pages 173-212

    Endocannabinoids, Monoamines and Stress

  11. No Access

    Book Chapter

    Pages 213-238

    Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain Disorders

  12. No Access

    Book Chapter

    Pages 239-254

    Endocannabinoid Signaling and the Regulation of the Serotonin System

  13. No Access

    Book Chapter

    Pages 255-275

    Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors

  14. No Access

    Book Chapter

    Pages 277-295

    Involvement of Serotonergic System in Cannabinoid Analgesia

  15. No Access

    Book Chapter

    Pages 297-323

    Cannabinoids, Monoamines, COMT and Schizophrenia: Pathobiological Mechanisms in Psychosis

  16. Back Matter

    Pages 325-337